A team of scientists at Cambridge University working in partnership with a few more in Estonia and Sweden have identified a molecule that may hinder or block the progression of Alzheimer’s disease at an important state of development. This news has sparked a whole new discussion of new line of treatments for this condition.
This is the first time in the history of Alzheimer’s disease that scientists have found a molecule that might put a stop to development of the disease. Furthermore, this also means that other molecules can be identified that may cease the growth of this neurological condition.
There are odd 520,000 people in the UK suffering from Alzheimer's, which is the most common form of dementia. Dementia is inching closer to become the biggest health hazard in Britain and is slowly catching up with growing number of cancer and heart diseases in men.
Alzheimer’s is a result of malfunctioning of proteins in the brain, which then stick to fibers. Over a period of time they form clusters known as oligomers which are poison the nerve cells. As the disease progresses to the second stage it sets off a chain reaction which leads to multiplicationof clusters. The cumulative effect of this leads to aggressive nature of the disease which progresses at a faster rate.
The molecule identified by Scientists at the Centre for Misfolding Diseases in Cambridge’s Chemistry Department, is a natural proteins known as Brichos. This protein can attach itself to the fibers restricting their merger and multiplication.